USANA Health Sciences, Inc. (USNA) Misses Q2 EPS by 14c

USANA Health Sciences, Inc. (NYSE: USNA) reported Q2 EPS of $1.36, $0.14 worse than the analyst estimate of $1.50. Revenue for the quarter came in at $188.3 million versus the consensus estimate of $198.3 million.

“USANA generated solid results during the second quarter, notwithstanding several factors that created a challenging year-over-year comparable,” said Dave Wentz, USANA’s Chief Executive Officer. “In 2013, we made a number of important changes to our business, including world-wide policy changes, enhancements to our Associate compensation plan and pricing initiatives. These changes have improved our core business by generating double digit year-over-year increases in our customer counts, Auto Order sales and check earners. As we anticipated and previously communicated, these changes have also created tough year-over-year comparables in 2014 and have caused our financial results to trail our operational progress. As we execute our 2014 strategies, we are confident that our performance will continue to accelerate during the second half of the year and we will deliver another year of record results in 2014. We are also committed to returning value to shareholders through our share repurchase program.”

For earnings history and earnings-related data on USANA Health Sciences, Inc. (USNA) click here.

You May Also Be Interested In

• Equifax (EFX) shares tumble as Q2, full-year guidance falls short
• F.N.B. Corp (FNB) Reports In-Line Q1 EPS
• Monarch Casino & Resort (MCRI) Misses Q1 EPS by 4c